Cargando…

MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6

Aberrantly expressed microRNAs contribute to the initiation and progression of human cancer. MiRNA-187 has been reported in nasopharyngeal, renal, pancreatic, prostate, and esophageal cancer, and acts as a tumor suppressor or oncogene. However, the underlying function of miRNA-187 in cervical cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Mao, Xue, Xiang-Yang, Liang, Shu-Zhen, Li, Yin-Xiong, Lv, You-Yong, He, Li-Hua, Xu, Ke-Cheng, Zhang, Li-Fang, Chen, Ji-Bing, Niu, Li-Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609891/
https://www.ncbi.nlm.nih.gov/pubmed/28968959
http://dx.doi.org/10.18632/oncotarget.17516
_version_ 1783265682178179072
author Lin, Mao
Xue, Xiang-Yang
Liang, Shu-Zhen
Li, Yin-Xiong
Lv, You-Yong
He, Li-Hua
Xu, Ke-Cheng
Zhang, Li-Fang
Chen, Ji-Bing
Niu, Li-Zhi
author_facet Lin, Mao
Xue, Xiang-Yang
Liang, Shu-Zhen
Li, Yin-Xiong
Lv, You-Yong
He, Li-Hua
Xu, Ke-Cheng
Zhang, Li-Fang
Chen, Ji-Bing
Niu, Li-Zhi
author_sort Lin, Mao
collection PubMed
description Aberrantly expressed microRNAs contribute to the initiation and progression of human cancer. MiRNA-187 has been reported in nasopharyngeal, renal, pancreatic, prostate, and esophageal cancer, and acts as a tumor suppressor or oncogene. However, the underlying function of miRNA-187 in cervical cancer remains largely unexplored. In the present study, we demonstrated significantly miRNA-187 down-regulation in cervical cancer tissues and cell lines compared to their normal counterparts. Kaplan-Meier analysis revealed that decreased miRNA-187 was closely associated with shorter overall survival and relapse-free survival. Gain- and loss-of-function studies showed that miRNA-187 suppressed cervical cancer cell proliferation, migration, and invasion, and promoted cervical cancer cell apoptosis. Furthermore, luciferase reporter assay determined that human papillomavirus 16 E6 was a direct functional target of miRNA-187. Taken together, our findings indicate the essential role of miRNA-187 in suppressing cervical cancer progression and indicate a novel link between miRNA-187 and human papillomavirus 16 E6 in cervical cancer.
format Online
Article
Text
id pubmed-5609891
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56098912017-09-29 MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6 Lin, Mao Xue, Xiang-Yang Liang, Shu-Zhen Li, Yin-Xiong Lv, You-Yong He, Li-Hua Xu, Ke-Cheng Zhang, Li-Fang Chen, Ji-Bing Niu, Li-Zhi Oncotarget Research Paper Aberrantly expressed microRNAs contribute to the initiation and progression of human cancer. MiRNA-187 has been reported in nasopharyngeal, renal, pancreatic, prostate, and esophageal cancer, and acts as a tumor suppressor or oncogene. However, the underlying function of miRNA-187 in cervical cancer remains largely unexplored. In the present study, we demonstrated significantly miRNA-187 down-regulation in cervical cancer tissues and cell lines compared to their normal counterparts. Kaplan-Meier analysis revealed that decreased miRNA-187 was closely associated with shorter overall survival and relapse-free survival. Gain- and loss-of-function studies showed that miRNA-187 suppressed cervical cancer cell proliferation, migration, and invasion, and promoted cervical cancer cell apoptosis. Furthermore, luciferase reporter assay determined that human papillomavirus 16 E6 was a direct functional target of miRNA-187. Taken together, our findings indicate the essential role of miRNA-187 in suppressing cervical cancer progression and indicate a novel link between miRNA-187 and human papillomavirus 16 E6 in cervical cancer. Impact Journals LLC 2017-04-29 /pmc/articles/PMC5609891/ /pubmed/28968959 http://dx.doi.org/10.18632/oncotarget.17516 Text en Copyright: © 2017 Lin et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Paper
Lin, Mao
Xue, Xiang-Yang
Liang, Shu-Zhen
Li, Yin-Xiong
Lv, You-Yong
He, Li-Hua
Xu, Ke-Cheng
Zhang, Li-Fang
Chen, Ji-Bing
Niu, Li-Zhi
MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
title MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
title_full MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
title_fullStr MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
title_full_unstemmed MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
title_short MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6
title_sort mir-187 overexpression inhibits cervical cancer progression by targeting hpv16 e6
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609891/
https://www.ncbi.nlm.nih.gov/pubmed/28968959
http://dx.doi.org/10.18632/oncotarget.17516
work_keys_str_mv AT linmao mir187overexpressioninhibitscervicalcancerprogressionbytargetinghpv16e6
AT xuexiangyang mir187overexpressioninhibitscervicalcancerprogressionbytargetinghpv16e6
AT liangshuzhen mir187overexpressioninhibitscervicalcancerprogressionbytargetinghpv16e6
AT liyinxiong mir187overexpressioninhibitscervicalcancerprogressionbytargetinghpv16e6
AT lvyouyong mir187overexpressioninhibitscervicalcancerprogressionbytargetinghpv16e6
AT helihua mir187overexpressioninhibitscervicalcancerprogressionbytargetinghpv16e6
AT xukecheng mir187overexpressioninhibitscervicalcancerprogressionbytargetinghpv16e6
AT zhanglifang mir187overexpressioninhibitscervicalcancerprogressionbytargetinghpv16e6
AT chenjibing mir187overexpressioninhibitscervicalcancerprogressionbytargetinghpv16e6
AT niulizhi mir187overexpressioninhibitscervicalcancerprogressionbytargetinghpv16e6